The first person to ever be cured of sickle cell anemia in Louisiana received revolutionary gene therapy. The treatment is now offered at this hospital.
Five seemingly unconnected Black and ethnic minority Londoners discover they have superpowers in the hit Netflix series "Supacell". The link between them? They all suffer from sickle cell anaemia, a ...
Sickle cell disease remains a major public health challenge in India, particularly among tribal populations. According to ...
Gene editing has delivered remarkable results against sickle cell disease. Now researchers are working to make these personalized treatments faster, cheaper, and available to far more patients.
Having a part of his spleen removed and a rare chronic disease hasn’t stopped 12-year-old E’Shon Guy from living a normal ...
Ahmedabad: Pharma major Zydus Lifesciences on Thursday received approval to conduct a Phase III clinical trial of Desidustat in patients with sickle cell disease, the company said in a stock exchange ...
Within 12 hours of landing in Florida in January, 2021, Sebastien Beauzile, then 17, was admitted to two separate hospitals. He had come to Florida to surprise his sister for her birthday. But instead ...
Children with sickle cell anemia are vulnerable to serious infections and stroke, but many do not receive the preventative care that could help them stay healthier for longer, a Children's Hospital ...
Every year, June 19 is observed as World Sickle Cell Awareness Day. The day aims to increase understanding of sickle cell disease (SCD), which is an inherited blood disorder that affects millions of ...
Family members have called for an independent investigation into CaSandra Pearson's death, saying she belonged in a hospital ...
SAN ANTONIO - The official cause of death for a Bexar County Jail inmate who died in May has finally been released.According to the Bexar County Medical Examiner's Office, the cause of death for ...
This deals another blow to tebapivat’s development prospects following its May 2026 termination in MDS due to efficacy ...